Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis

Gynecol Obstet Invest. 2010;70(1):47-54. doi: 10.1159/000286379. Epub 2010 Feb 19.

Abstract

Background/aim: The aim of this meta-analysis was to evaluate whether IV albumin infusion around the time of oocyte retrieval prevents ovarian hyperstimulation syndrome (OHSS) and affects the pregnancy rate.

Methods: A meta-analysis of data from 9 randomized controlled trials including 1,613 women at high risk for developing OHSS in in vitro fertilization cycles was performed.

Results: The combined incidence of severe OHSS was 6.0% in the IV albumin group and 7.9% in saline or no treatment groups. These rates were statistically not different (RR = 0.80, 95% CI = 0.57-1.12). Treatment with IV albumin significantly lowered the pregnancy rates (RR = 0.85, 95% CI = 0.74-0.98).

Conclusions: The combined data presented in this meta-analysis do not support a benefit for IV albumin around the time of oocyte retrieval in preventing OHSS and even showed a deleterious effect on the pregnancy rate.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Female
  • Humans
  • Injections, Intravenous
  • Oocyte Retrieval / methods*
  • Ovarian Hyperstimulation Syndrome / drug therapy*
  • Ovarian Hyperstimulation Syndrome / prevention & control*
  • Pregnancy
  • Pregnancy Rate*
  • Serum Albumin / administration & dosage*
  • Treatment Failure

Substances

  • Serum Albumin